Autopsy report · NCT04242147
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors
Cause of deathNo reason given
Life of this trial
- Registered 3 years 1 month before it started.
- Ran for about 9 months before it stopped.
- 45 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Kadmon, a Sanofi Company
- Sponsor type
- Industry
- Conditions
- Solid Tumor
- Interventions
- KD033 (SAR445710)
- Participants
- 45
- Sites
- 5
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.